+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV/AIDS Drugs Market Research Reports

US HIV Market and Competitive Landscape - 2022 - Product Thumbnail Image

US HIV Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global HIV Treatment Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global HIV Treatment Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Human Immunodeficiency Virus (HIV) Therapeutics - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Therapeutics - Global Drug Forecast and Market Analysis to 2029

  • Report
  • February 2021
  • 254 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2029 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2029

  • Report
  • February 2021
  • 58 Pages
  • Global
From
HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal - Product Thumbnail Image

HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal

  • Report
  • December 2019
  • 63 Pages
  • Global
From
Disease Analysis: HIV Treatment - Product Thumbnail Image

Disease Analysis: HIV Treatment

  • Report
  • April 2021
  • 64 Pages
  • Global
HIV Disease Coverage Forecast and Market Analysis to 2024 - Product Thumbnail Image

HIV Disease Coverage Forecast and Market Analysis to 2024

  • Report
  • January 2019
  • 717 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2020 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 1285 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • August 2022
  • 95 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model

  • Report
  • April 2019
  • Global
From
HIV Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) - Product Thumbnail Image

HIV Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

  • Report
  • June 2021
  • Global
From
Truvada ([emtricitabine + tenofovir disoproxil fumarate (TDF)]; Gilead/Japan Tobacco) Drug Overview 2019 - Product Thumbnail Image

Truvada ([emtricitabine + tenofovir disoproxil fumarate (TDF)]; Gilead/Japan Tobacco) Drug Overview 2019

  • Report
  • June 2019
  • 15 Pages
  • Japan
Viread - API Insight, 2022 - Product Thumbnail Image

Viread - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Sustiva - API Insight, 2022 - Product Thumbnail Image

Sustiva - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Norvir SEC - API Insight, 2022 - Product Thumbnail Image

Norvir SEC - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Kaletra - API Insight, 2022 - Product Thumbnail Image

Kaletra - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Isentress - API Insight, 2022 - Product Thumbnail Image

Isentress - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Selzentry - API Insight, 2022 - Product Thumbnail Image

Selzentry - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Truvada - API Insight, 2022 - Product Thumbnail Image

Truvada - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Prezista - API Insight, 2022 - Product Thumbnail Image

Prezista - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus. The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more